HRT Financial’s Accolade Inc ACCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-66,405
Closed -$894K 3257
2023
Q2
$894K Buy
66,405
+50,646
+321% +$658K 0.01% 1016
2023
Q1
$226K Sell
15,759
-7,329
-32% -$83K ﹤0.01% 1874
2022
Q4
$179K Buy
+23,088
New +$220K ﹤0.01% 1958
2022
Q3
Sell
-75,479
Closed -$558K 3643
2022
Q2
$558K Buy
+75,479
New +$660K 0.01% 1404
2022
Q1
Sell
-53,248
Closed -$1.4M 4028
2021
Q4
$1.4M Buy
+53,248
New +$1.74M 0.01% 880
2021
Q1
Sell
-17,731
Closed -$771K 3247
2020
Q4
$771K Buy
+17,731
New +$787K 0.02% 802

Other funds holding ACCD

HRT Financial's ACCD Position: Q3 2023 in Review

HRT Financial sold out of Accolade Inc (ACCD) in Q3 2023, closing a stake of 66,405 shares — an estimated $894K sold.

HRT Financial first reported a position in ACCD in Q4 2020 and held it in 6 quarters. The position peaked at $1.4M in Q4 2021. 150 funds tracked by Wall St. Rank hold ACCD as of Q3 2023.

  • HRT Financial reported no remaining Accolade Inc position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 66,405 Accolade Inc shares in Q3 2023, an estimated $894K.
  • HRT Financial first reported a position in Accolade Inc in Q4 2020 and held it in 6 quarters.
  • HRT Financial's Accolade Inc position peaked at $1.4M in Q4 2021.
  • 150 funds tracked by Wall St. Rank held Accolade Inc as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.